• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铋剂在治疗幽门螺杆菌感染中的作用:最新进展。

The actions of bismuth in the treatment of Helicobacter pylori infections: an update.

机构信息

Key Laboratory of Gene Engineering of the Ministry of Education, College of Life Sciences, Sun Yat-Sen University, Guangzhou 510275, China.

出版信息

Metallomics. 2012 Mar;4(3):239-43. doi: 10.1039/c2mt00180b. Epub 2012 Feb 23.

DOI:10.1039/c2mt00180b
PMID:22358069
Abstract

Helicobacter pylori causes various gastric diseases, such as gastritis, peptic ulcerations and gastric cancer. Bismuth-based triple or quadruple therapies have been commonly recommended for the treatment of H. pylori infections. Up to now, the molecular mechanisms by which bismuth inhibits the growth of H. pylori are far from clear. The present concise review intends to cover the most recent reports and discoveries in the field of the inhibitory mechanism of bismuth against H. pylori as well as the bacterial protective response to drug treatment, which will help us to further understand the molecular mechanisms underlying the actions of metal-based drugs and stimulate further development of effective anti-bacterial drugs.

摘要

幽门螺杆菌可引起多种胃部疾病,如胃炎、消化性溃疡和胃癌。含铋三联或四联疗法已被广泛推荐用于治疗幽门螺杆菌感染。迄今为止,铋抑制幽门螺杆菌生长的分子机制仍不清楚。本综述旨在涵盖有关铋抑制幽门螺杆菌的抑制机制以及细菌对药物治疗的保护反应的最新报告和发现,这将有助于我们进一步了解基于金属药物作用的分子机制,并激发有效抗菌药物的进一步开发。

相似文献

1
The actions of bismuth in the treatment of Helicobacter pylori infections: an update.铋剂在治疗幽门螺杆菌感染中的作用:最新进展。
Metallomics. 2012 Mar;4(3):239-43. doi: 10.1039/c2mt00180b. Epub 2012 Feb 23.
2
Inhibition of fumarase by bismuth(III): implications for the tricarboxylic acid cycle as a potential target of bismuth drugs in Helicobacter pylori.三价铋对延胡索酸酶的抑制作用:三羧酸循环可能成为幽门螺杆菌中铋剂药物的作用靶点。
Biometals. 2012 Feb;25(1):95-102. doi: 10.1007/s10534-011-9485-7. Epub 2011 Aug 5.
3
[Therapy of Helicobacter pylori infection: current status].[幽门螺杆菌感染的治疗:现状]
Z Gastroenterol. 1993 Jul-Aug;31(7-8):459-63.
4
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.枸橼酸铋雷尼替丁、阿莫西林和克拉霉素两周疗法对克拉霉素敏感及耐药病例中幽门螺杆菌根除的疗效。
Turk J Gastroenterol. 2005 Dec;16(4):203-6.
5
[The association between Helicobacter pylori and gastric cancer: the role of infection's eradication. Recent advances].[幽门螺杆菌与胃癌的关联:感染根除的作用。最新进展]
Recenti Prog Med. 2010 Feb;101(2):66-9.
6
Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.荟萃分析:抗生素耐药状况对幽门螺杆菌三联和四联一线疗法疗效的影响
Aliment Pharmacol Ther. 2007 Aug 1;26(3):343-57. doi: 10.1111/j.1365-2036.2007.03386.x.
7
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.甲硝唑+四环素+枸橼酸铋钾与奥美拉唑+阿莫西林+枸橼酸铋钾治疗幽门螺杆菌相关性胃炎和消化性溃疡疾病的药理作用比较
Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S103-7.
8
Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.荟萃分析:与一线抗幽门螺杆菌四联疗法相关的疗效、不良事件及依从性
Aliment Pharmacol Ther. 2004 Nov 15;20(10):1071-82. doi: 10.1111/j.1365-2036.2004.02248.x.
9
One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.枸橼酸雷尼替丁铋与基于枸橼酸铋钾的抗幽门螺杆菌三联疗法一周对比:一项前瞻性随机对照试验
Am J Gastroenterol. 1999 Mar;94(3):721-4. doi: 10.1111/j.1572-0241.1999.00942.x.
10
Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.幽门螺杆菌与消化性溃疡疾病。重新审视治疗方法。
Postgrad Med. 1993 Sep 1;94(3):38-40, 43-5.

引用本文的文献

1
Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Infection.铋剂加用标准三联疗法与联合疗法的个体化治疗:幽门螺杆菌感染的一线治疗方案
Korean J Helicobacter Up Gastrointest Res. 2023 Jun;23(2):118-124. doi: 10.7704/kjhugr.2022.0058. Epub 2023 Apr 10.
2
Efficacy and safety of Jinghua Weikang capsule combined with amoxicillin-furazolidone triple/quadruple therapies in the rescue treatment of infection.荆花胃康胶囊联合阿莫西林-呋喃唑酮三联/四联疗法在感染性疾病挽救治疗中的疗效与安全性。
Front Med (Lausanne). 2025 Mar 25;12:1531620. doi: 10.3389/fmed.2025.1531620. eCollection 2025.
3
Efficacy and Safety of Modified Bismuth Quadruple Therapy for First-Line Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
改良铋剂四联疗法一线根除幽门螺杆菌的疗效与安全性:一项随机对照试验的系统评价和Meta分析
Microorganisms. 2025 Feb 26;13(3):519. doi: 10.3390/microorganisms13030519.
4
Bismuth(III) complexes of Schiff bases derived from aliphatic amines: interaction with biomolecules and antimicrobial activity.脂肪胺衍生席夫碱的铋(III)配合物:与生物分子的相互作用及抗菌活性。
J Biol Inorg Chem. 2025 Apr;30(3):257-269. doi: 10.1007/s00775-025-02107-y. Epub 2025 Mar 8.
5
Selective inhibition of NikA mediated Ni(II) import in E. coli by the Indium(III)-EDTA complex.铟(III)-乙二胺四乙酸络合物对大肠杆菌中NikA介导的镍(II)导入的选择性抑制作用。
Metallomics. 2025 Mar 28;17(4). doi: 10.1093/mtomcs/mfaf008.
6
Should Metronidazole Be Included in Second-Line Treatment After Standard Triple Therapy for Helicobacter pylori?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.幽门螺杆菌标准三联疗法后二线治疗中是否应包含甲硝唑?:随机对照试验的系统评价和荟萃分析
Helicobacter. 2025 Jan-Feb;30(1):e70010. doi: 10.1111/hel.70010.
7
Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome.铋化合物的生物学活性:新发现综述及尚未克服的旧挑战。
Molecules. 2023 Aug 7;28(15):5921. doi: 10.3390/molecules28155921.
8
Metal-Based Nanoparticles: A Prospective Strategy for Treatment.基于金属的纳米粒子:一种有前景的治疗策略。
Int J Nanomedicine. 2023 May 9;18:2413-2429. doi: 10.2147/IJN.S405052. eCollection 2023.
9
Zinc carnosine-based modified bismuth quadruple therapy standard triple therapy for eradication: A randomized controlled study.基于肌肽锌的改良铋四联疗法与标准三联疗法根除幽门螺杆菌的随机对照研究
World J Clin Cases. 2022 Jan 7;10(1):227-235. doi: 10.12998/wjcc.v10.i1.227.
10
Chilean Rhubarb, (Molina) Mirb. (Gunneraceae): UHPLC-ESI-Orbitrap-MS Profiling of Aqueous Extract and its Anti- Activity.智利大黄,(莫利纳)米尔贝。(贡纳尔科属):水提取物的超高效液相色谱-电喷雾电离-轨道阱质谱分析及其抗活性。
Front Pharmacol. 2021 Jan 27;11:583961. doi: 10.3389/fphar.2020.583961. eCollection 2020.